Clinical trial
Prevention of Cardiac and Vascular Events in Patients With NGT/IGT.
NCT00408577 · IRCCS San Raffaele, Other · Completed
Key facts
| NCT number | NCT00408577 |
|---|---|
| Title | Prevention of Cardiac and Vascular Events in Patients With NGT/IGT. |
| Official title | Prevention of Cardiovascular Relapses by L-Arginine Oral Administration in Patients With CAD and IGT and/or Insulin Resistance. |
| Lead sponsor | IRCCS San Raffaele, Other |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Cardiovascular Disease |
| Intervention type | Drug |
| Interventions | L-arginine |
| Enrollment | 150 |
| Start date | Nov 1, 2004 |
| Completion | Nov 1, 2006 |
| First posted | Dec 7, 2006 |
| Last update posted | Dec 12, 2006 |
| Countries | Italy |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: